These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4655292)

  • 1. 5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis.
    Sjöström R; Roos BE
    Eur J Clin Pharmacol; 1972 Jun; 4(3):170-6. PubMed ID: 4655292
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-Hydroxyindole acetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis and the effect of probenecid treatment.
    Sjöström R
    Eur J Clin Pharmacol; 1973 Aug; 6(2):75-80. PubMed ID: 4588853
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of lithium treatment on manic symptoms and levels of monoamine metabolites in cerebrospinal fluid of manic depressive patients.
    Fyrö B; Petterson U; Sedvall G
    Psychopharmacologia; 1975 Oct; 44(1):99-103. PubMed ID: 1105629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lumbar CSF 5-hydroxyindoleacetic acid and homovanillic acid in affective syndromes.
    Bowers MB
    J Nerv Ment Dis; 1974 May; 158(5):325-30. PubMed ID: 4823933
    [No Abstract]   [Full Text] [Related]  

  • 5. Estimation of brain amine metabolism in affective illness: cerebrospinal fluid studies utilizing probenecid.
    Post RM; Goodwin FK
    Psychother Psychosom; 1974; 23(1-6):142-58. PubMed ID: 4278087
    [No Abstract]   [Full Text] [Related]  

  • 6. Biogenic amine metabolites in cerebrospinal fluid of depressed and manic patients.
    Mendels J; Frazer A; Fitzgerald RG; Ramsey TA; Stokes JW
    Science; 1972 Mar; 175(4028):1380-2. PubMed ID: 5059569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of manic-depressive psychosis from cerebrospinal fluid concentration of 5-hydroxyindoleacetic acid.
    Sjöström R
    Adv Biochem Psychopharmacol; 1974; 11(0):369-75. PubMed ID: 4845705
    [No Abstract]   [Full Text] [Related]  

  • 8. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (HIAA) in the CSF after administration of probenecid in Huntington's chorea. Effect of lithium carbonate].
    Livrea P; Di Reda L; Ragno G; Germinario L; Papagno G
    Riv Neurobiol; 1977; 23(3):149-59. PubMed ID: 154166
    [No Abstract]   [Full Text] [Related]  

  • 9. CSF acid monoamine metabolities as a possible reflection of central MAO activity in chronic schizophrenia.
    Bowers MB
    Biol Psychiatry; 1976 Apr; 11(2):245-9. PubMed ID: 971448
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.
    Goodwin FK; Post RM; Dunner DL; Gordon EK
    Am J Psychiatry; 1973 Jan; 130(1):73-9. PubMed ID: 4345466
    [No Abstract]   [Full Text] [Related]  

  • 11. 5-Hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) following probenecid in acute psychotic patients treated with phenothiazines.
    Bowers MB
    Psychopharmacologia; 1973 Feb; 28(4):309-18. PubMed ID: 4572012
    [No Abstract]   [Full Text] [Related]  

  • 12. Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.
    Olsson R; Roos BE
    Nature; 1968 Aug; 219(5153):502-3. PubMed ID: 5668438
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid.
    Korf J; van Praag HM; Sebens JB
    Biochem Pharmacol; 1971 Mar; 20(3):659-68. PubMed ID: 5150161
    [No Abstract]   [Full Text] [Related]  

  • 14. 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid and brain of different rabbit breeds after treatment with probenecid.
    Andersson H; Roos BE
    J Pharm Pharmacol; 1972 Feb; 24(2):165-6. PubMed ID: 4401976
    [No Abstract]   [Full Text] [Related]  

  • 15. Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.
    Guldberg HC; Ashcroft GW; Crawford TB
    Life Sci; 1966 Sep; 5(17):1571-5. PubMed ID: 5970680
    [No Abstract]   [Full Text] [Related]  

  • 16. Lithium: clinical effects and cerebrospinal fluid acid monoamine metabolites.
    Bowers MB; Heninger GR
    Commun Psychopharmacol; 1977; 1(2):135-45. PubMed ID: 603996
    [No Abstract]   [Full Text] [Related]  

  • 17. Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania.
    Dencker SJ; Malm U; Roos BE; Werdinius B
    J Neurochem; 1966 Dec; 13(12):1545-8. PubMed ID: 5962034
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebrospinal fluid and plasma monoamines and their metabolites in euthymic bipolar patients.
    Berrettini WH; Nurnberger JI; Scheinin M; Seppala T; Linnoila M; Narrow W; Simmons-Alling S; Gershon ES
    Biol Psychiatry; 1985 Mar; 20(3):257-69. PubMed ID: 2579681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness.
    Ashcroft GW; Blackburn IM; Eccleston D; Glen AI; Hartley W; Kinloch NE; Lonergan M; Murray LG; Pullar IA
    Psychol Med; 1973 Aug; 3(3):319-25. PubMed ID: 4147078
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of convulsive therapy on 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid in endogenous depression.
    Nordin G; Ottosson JO; Roos BE
    Psychopharmacologia; 1971; 20(4):315-20. PubMed ID: 5561655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.